Nivolumab As Second-Line Treatment of Patients with Metastatic Renal Cell Carcinoma with High or Normal Fibrinogen Levels: A Prospective, Cohort Study
JOURNAL OF CLINICAL ONCOLOGY(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CLINICAL ONCOLOGY(2023)